Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Bactiguard Holding AB ( ($SE:BACTI.B) ) has issued an update.
Bactiguard Holding AB has called its Annual General Meeting for 19 May 2026 in Stockholm, outlining participation rules for shareholders, including record date registration, notice requirements, and procedures for proxy representation and trustee-registered shares. The agenda covers standard governance items such as approval of financial statements, discharge of liability for the board and CEO, election of directors and auditors, and authorization for new share issues, repurchases, and a long-term share-based incentive program.
The nomination committee proposes a five-member board, Magnus Lindstedt as AGM chair, and a registered accounting firm as auditor, alongside board fees of SEK 750,000 for the chair and SEK 400,000 for each of the other four directors. The board also recommends that no dividend be paid for the 2025 financial year, signaling a prioritization of capital retention that may impact shareholder returns but could support ongoing investments and the company’s long-term strategic initiatives.
More about Bactiguard Holding AB
Bactiguard Holding AB is a Swedish medical technology company focused on infection prevention solutions for healthcare. The company develops and provides coated medical devices and related technologies aimed at reducing healthcare-associated infections, with its shares registered in the Euroclear Sweden AB system and traded publicly.
Average Trading Volume: 9,887
Technical Sentiment Signal: Sell
Current Market Cap: SEK602.8M
See more data about BACTI.B stock on TipRanks’ Stock Analysis page.